| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© Oxford University Press 2007.
NEWS |
Breast Cancer Decline Mirrors Fall in Hormone Use, Spurs Both Debate and Research
| The first 10% of the full text of this article appears below. |
A decline in breast cancer incidence from 2002 to 2003 may stem from the sudden fall in postmenopausal hormone use in the same period, according to a study presented at the San Antonio Breast Cancer Symposium in December.
The finding garnered massive media attention for several days, but that was just the beginning of its impact. In the research community, it has fueled plans for more studiesfurther analyses, modeling studies, and closer scrutiny of ongoing surveillance dataas statisticians, epidemiologists, and clinicians seek to confirm the association and sort out its long-term implications.
The analysis, presented in San Antonio by Peter Ravdin, M.D., of the University of Texas M. D. Anderson Cancer Center in Houston, used data from the Surveillance, Epidemiology, and End Results (SEER) database showing that breast cancer incidence dropped by 7% from 2002 to 2003. Ravdin and his
Duration of the Effect?
Another Cause?
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
N. Krieger Hormone therapy and the rise and perhaps fall of US breast cancer incidence rates: critical reflections Int. J. Epidemiol., June 1, 2008; 37(3): 627 - 637. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. F. Anderson, A. S. Reiner, R. K. Matsuno, and R. M. Pfeiffer Shifting Breast Cancer Trends in the United States J. Clin. Oncol., September 1, 2007; 25(25): 3923 - 3929. [Abstract] [Full Text] [PDF] |
||||

